Report - ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS...No data are available regarding the concomitant use of partial opioid agonists (e.g. buprenorphine) with ziconotide. 4.6 Fertility, pregnancy

Please pass captcha verification before submit form